Foot and Mouth Disease Vaccine Market, by Vaccine Type ((Conventional Vaccine [Aluminum Hydroxide based vaccines and Oil based vaccines] and Emergency Vaccines) and by Animal Type (Cattle, Swine, Goat and Sheep, and Others) and by Region (North America, L

Foot and Mouth Disease Vaccine Market, by Vaccine Type ((Conventional Vaccine [Aluminum Hydroxide based vaccines and Oil based vaccines] and Emergency Vaccines) and by Animal Type (Cattle, Swine, Goat and Sheep, and Others) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Foot and Mouth Disease (FMD) is infectious disease in domestic animals caused due to viral strain Aphtovirus of the family picornaviridae. It majorly affects cloven hooved livestock such as cattle, goat, sheep, swine, and other animals. It can spread through both direct and indirect modes. Foot and mouth disease causes high morbidity in animals and results into significant economic loss due to decreased milk production, permanent hoof damage, and chronic mastitis. Although adult animals can recover from the disease, mortality is high among young animals, as immunity is not well developed due to which foot and mouth disease vaccination is essential. The disease is characterized by fever and blistery sore on tongue, lips and oral cavity. Foot and mouth disease is best preventable by vaccinating the livestock. There are total seven strains (A, O, C, SAT1, SAT2, SAT3, and Asia1) of the virus that affect animals, symptoms produced are similar in each strain and they can be distinguished only through laboratory tests. Various regions around the world are affected by different set of viral strains. Therefore each strain requires specific vaccine to prevent the infection. Inactivated vaccines are available to prevent animals from being infected by foot and mouth disease.

Market Dynamics

Increasing licensing agreements between government organization and key players are expected to drive market growth of the global foot and mouth disease vaccine market over the forecast period. For instance, in September 2019, Pirbright Institute, a research institute dedicated to the study of infectious diseases of farm animals, and its research partners had granted MSD Animal Health, the organizational company that offers innovative veterinary pharmaceuticals and vaccines services, an exclusive commercial licence for a new, effective, and affordable vaccine to protect livestock against several serotypes of foot-and-mouth disease virus. The vaccine has been developed from basic science to animal trials as a result of long-standing collaborations between Pirbright, the University of Oxford, Diamond Light Source, the University of Reading, and MSD Animal Health, a division of Merck & Co., Inc., who will be taken in 2022 forward the new technology into development, registration and manufacturing.

Key features of the study:

• This report provides an in-depth analysis of the global foot and mouth disease vaccine market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global foot and mouth disease vaccine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Agrovet Indian Immunologicals Ltd., MSD Animal Health, Vallee SA, Bayer HealthCare, Brilliant Bio Pharma Ltd., Intervet, Biovet, Merial, China Animal Husbandry Co., Ltd., Biogénesis-Bagó S.A, Vetal Animal Health Products S.A.VETAL Animal Health Products, and Vecol S.A.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global foot and mouth disease vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global foot and mouth disease vaccine market

Detailed Segmentation:

• Global Foot and Mouth Disease Vaccine Market, By Vaccine Type:
• Conventional Vaccine
• Aluminum Hydroxide based vaccine
• Oil based vaccines
• Emergency Vaccines
• Global Foot and Mouth Disease Vaccine Market, By Animal Type:
• Cattle
• Sheep and Goat
• Swine
• Others
• Global Foot and Mouth Disease Vaccine Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Agrovet*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• India Immunologicals Ltd.
• Merck Animal Health
• Shanghai Hile Bio-Pharmaceutical Co., Ltd.
• Vallee SA
• Brilliant Bio Pharma Ltd
• Merial
• China Animal Husbandry Co., Ltd.
• Biogénesis-Bagó S.A.
• Vetal Animal Health Products S.A.
• Vecol S

“*” marked represents similar segmentation in other categories in the respective section.